Cargando…
MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34(+) Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia
OBJECTIVE: In patients with type 2 diabetes (T2D) and critical limb ischemia (CLI), migration of circulating CD34(+) cells predicted cardiovascular mortality at 18 months after revascularization. This study aimed to provide long-term validation and mechanistic understanding of the biomarker. RESEARC...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305013/ https://www.ncbi.nlm.nih.gov/pubmed/32358022 http://dx.doi.org/10.2337/dc19-2227 |
_version_ | 1783548373830205440 |
---|---|
author | Spinetti, Gaia Sangalli, Elena Tagliabue, Elena Maselli, Davide Colpani, Ornella Ferland-McCollough, David Carnelli, Franco Orlando, Patrizia Paccagnella, Agostino Furlan, Anna Stefani, Piero Maria Sambado, Luisa Sambataro, Maria Madeddu, Paolo |
author_facet | Spinetti, Gaia Sangalli, Elena Tagliabue, Elena Maselli, Davide Colpani, Ornella Ferland-McCollough, David Carnelli, Franco Orlando, Patrizia Paccagnella, Agostino Furlan, Anna Stefani, Piero Maria Sambado, Luisa Sambataro, Maria Madeddu, Paolo |
author_sort | Spinetti, Gaia |
collection | PubMed |
description | OBJECTIVE: In patients with type 2 diabetes (T2D) and critical limb ischemia (CLI), migration of circulating CD34(+) cells predicted cardiovascular mortality at 18 months after revascularization. This study aimed to provide long-term validation and mechanistic understanding of the biomarker. RESEARCH DESIGN AND METHODS: The association between CD34(+) cell migration and cardiovascular mortality was reassessed at 6 years after revascularization. In a new series of T2D-CLI and control subjects, immuno-sorted bone marrow CD34(+) cells were profiled for miRNA expression and assessed for apoptosis and angiogenesis activity. The differentially regulated miRNA-21 and its proapoptotic target, PDCD4, were titrated to verify their contribution in transferring damaging signals from CD34(+) cells to endothelial cells. RESULTS: Multivariable regression analysis confirmed that CD34(+) cell migration forecasts long-term cardiovascular mortality. CD34(+) cells from T2D-CLI patients were more apoptotic and less proangiogenic than those from control subjects and featured miRNA-21 downregulation, modulation of several long noncoding RNAs acting as miRNA-21 sponges, and upregulation of the miRNA-21 proapoptotic target PDCD4. Silencing miR-21 in control CD34(+) cells phenocopied the T2D-CLI cell behavior. In coculture, T2D-CLI CD34(+) cells imprinted naive endothelial cells, increasing apoptosis, reducing network formation, and modulating the TUG1 sponge/miRNA-21/PDCD4 axis. Silencing PDCD4 or scavenging reactive oxygen species protected endothelial cells from the negative influence of T2D-CLI CD34(+) cells. CONCLUSIONS: Migration of CD34(+) cells predicts long-term cardiovascular mortality in T2D-CLI patients. An altered paracrine signaling conveys antiangiogenic and proapoptotic features from CD34(+) cells to the endothelium. This damaging interaction may increase the risk for life-threatening complications. |
format | Online Article Text |
id | pubmed-7305013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-73050132020-06-23 MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34(+) Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia Spinetti, Gaia Sangalli, Elena Tagliabue, Elena Maselli, Davide Colpani, Ornella Ferland-McCollough, David Carnelli, Franco Orlando, Patrizia Paccagnella, Agostino Furlan, Anna Stefani, Piero Maria Sambado, Luisa Sambataro, Maria Madeddu, Paolo Diabetes Care Pathophysiology/Complications OBJECTIVE: In patients with type 2 diabetes (T2D) and critical limb ischemia (CLI), migration of circulating CD34(+) cells predicted cardiovascular mortality at 18 months after revascularization. This study aimed to provide long-term validation and mechanistic understanding of the biomarker. RESEARCH DESIGN AND METHODS: The association between CD34(+) cell migration and cardiovascular mortality was reassessed at 6 years after revascularization. In a new series of T2D-CLI and control subjects, immuno-sorted bone marrow CD34(+) cells were profiled for miRNA expression and assessed for apoptosis and angiogenesis activity. The differentially regulated miRNA-21 and its proapoptotic target, PDCD4, were titrated to verify their contribution in transferring damaging signals from CD34(+) cells to endothelial cells. RESULTS: Multivariable regression analysis confirmed that CD34(+) cell migration forecasts long-term cardiovascular mortality. CD34(+) cells from T2D-CLI patients were more apoptotic and less proangiogenic than those from control subjects and featured miRNA-21 downregulation, modulation of several long noncoding RNAs acting as miRNA-21 sponges, and upregulation of the miRNA-21 proapoptotic target PDCD4. Silencing miR-21 in control CD34(+) cells phenocopied the T2D-CLI cell behavior. In coculture, T2D-CLI CD34(+) cells imprinted naive endothelial cells, increasing apoptosis, reducing network formation, and modulating the TUG1 sponge/miRNA-21/PDCD4 axis. Silencing PDCD4 or scavenging reactive oxygen species protected endothelial cells from the negative influence of T2D-CLI CD34(+) cells. CONCLUSIONS: Migration of CD34(+) cells predicts long-term cardiovascular mortality in T2D-CLI patients. An altered paracrine signaling conveys antiangiogenic and proapoptotic features from CD34(+) cells to the endothelium. This damaging interaction may increase the risk for life-threatening complications. American Diabetes Association 2020-07 2020-05-01 /pmc/articles/PMC7305013/ /pubmed/32358022 http://dx.doi.org/10.2337/dc19-2227 Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
spellingShingle | Pathophysiology/Complications Spinetti, Gaia Sangalli, Elena Tagliabue, Elena Maselli, Davide Colpani, Ornella Ferland-McCollough, David Carnelli, Franco Orlando, Patrizia Paccagnella, Agostino Furlan, Anna Stefani, Piero Maria Sambado, Luisa Sambataro, Maria Madeddu, Paolo MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34(+) Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia |
title | MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34(+) Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia |
title_full | MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34(+) Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia |
title_fullStr | MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34(+) Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia |
title_full_unstemmed | MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34(+) Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia |
title_short | MicroRNA-21/PDCD4 Proapoptotic Signaling From Circulating CD34(+) Cells to Vascular Endothelial Cells: A Potential Contributor to Adverse Cardiovascular Outcomes in Patients With Critical Limb Ischemia |
title_sort | microrna-21/pdcd4 proapoptotic signaling from circulating cd34(+) cells to vascular endothelial cells: a potential contributor to adverse cardiovascular outcomes in patients with critical limb ischemia |
topic | Pathophysiology/Complications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305013/ https://www.ncbi.nlm.nih.gov/pubmed/32358022 http://dx.doi.org/10.2337/dc19-2227 |
work_keys_str_mv | AT spinettigaia microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT sangallielena microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT tagliabueelena microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT masellidavide microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT colpaniornella microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT ferlandmccolloughdavid microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT carnellifranco microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT orlandopatrizia microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT paccagnellaagostino microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT furlananna microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT stefanipieromaria microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT sambadoluisa microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT sambataromaria microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia AT madeddupaolo microrna21pdcd4proapoptoticsignalingfromcirculatingcd34cellstovascularendothelialcellsapotentialcontributortoadversecardiovascularoutcomesinpatientswithcriticallimbischemia |